Moury Pierre-Henri, Béhouche Alexandre, Bailly Sébastien, Durand Zoé, Dessertaine Géraldine, Pollet Angelina, Jaber Samir, Verges Samuel, Albaladejo Pierre
Pôle Anesthésie-Réanimation, Grenoble Alpes University, Grenoble, France.
Univ. Grenoble Alpes, Inserm, Grenoble Alpes University Hospital, HP2 Laboratory, Grenoble, France.
Ann Intensive Care. 2024 Mar 8;14(1):38. doi: 10.1186/s13613-024-01264-8.
The incidence, causes and impact of diaphragm thickness evolution in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for cardiogenic shock are unknown. Our study investigates its evolution during the first week of VA-ECMO and its relationship with sweep gas flow settings.
We conducted a prospective monocentric observational study in a 12-bed ICU in France, enrolling patients on the day of the VA-ECMO implantation. The diaphragm thickness and the diaphragm thickening fraction (as index of contractile activity, dTF; dTF < 20% defined a low contractile activity) were daily measured for one week using ultrasound. Factors associated with diaphragm thickness evolution (categorized as increased, stable, or atrophic based on > 10% modification from baseline to the last measurement), early extubation role (< day4), and patients outcome at 60 days were investigated. Changes in diaphragm thickness, the primary endpoint, was analysed using a mixed-effect linear model (MLM).
Of the 29 included patients, seven (23%) presented diaphragm atrophy, 18 remained stable (60%) and 4 exhibited an increase (17%). None of the 13 early-extubated patients experienced diaphragm atrophy, while 7 (46%) presented a decrease when extubated later (p-value = 0.008). Diaphragm thickness changes were not associated with the dTF (p-value = 0.13) but with sweep gas flow (Beta = - 3; Confidence Interval at 95% (CI) [- 4.8; - 1.2]. p-value = 0.001) and pH (Beta = - 2; CI [- 2.9; - 1]. p-value < 0.001) in MLM. The dTF remained low (< 20%) in 20 patients (69%) at the study's end and was associated with sweep gas flow evolution in MLM (Beta = - 2.8; 95% CI [- 5.2; - 0.5], p-value = 0.017). Odds ratio of death at 60 days in case of diaphragm atrophy by day 7 was 8.50 ([1.4-74], p = 0.029).
In our study, diaphragm thickness evolution was frequent and not associated with the diaphragm thickening fraction. Diaphragm was preserved from atrophy in case of early extubation with ongoing VA-ECMO assistance. Metabolic disorders resulting from organ failures and sweep gas flow were linked with diaphragm thickness evolution. Preserved diaphragm thickness in VA-ECMO survivors emphasizes the importance of diaphragm-protective strategies, including meticulous sweep gas flow titration.
在用于心源性休克的静脉 - 动脉体外膜肺氧合(VA - ECMO)中,膈肌厚度变化的发生率、原因及影响尚不清楚。我们的研究调查了其在VA - ECMO治疗第一周内的变化及其与扫气流量设置的关系。
我们在法国一家拥有12张床位的重症监护病房进行了一项前瞻性单中心观察性研究,在VA - ECMO植入当天纳入患者。使用超声连续一周每日测量膈肌厚度和膈肌增厚分数(作为收缩活动指标,dTF;dTF < 20%定义为低收缩活动)。研究了与膈肌厚度变化(根据从基线到最后一次测量的变化> 10%分为增加、稳定或萎缩)、早期拔管作用(<第4天)以及患者60天结局相关的因素。将膈肌厚度变化这一主要终点,使用混合效应线性模型(MLM)进行分析。
在纳入的29例患者中,7例(23%)出现膈肌萎缩,18例保持稳定(60%),4例增厚(17%)。13例早期拔管患者均未出现膈肌萎缩,而后期拔管的患者中有7例(46%)出现膈肌厚度下降(p值 = 0.008)。MLM分析显示,膈肌厚度变化与dTF无关(p值 = 0.13),但与扫气流量(β = - 3;95%置信区间(CI)[- 4.8;- 1.2],p值 = 0.001)和pH(β = - 2;CI [- 2.9;- 1],p值 < 0.001)有关。研究结束时,20例患者(69%)dTF仍较低(< 20%),且MLM分析显示其与扫气流量变化有关(β = - 2.8;95% CI [- 5.2;- 0.5],p值 = 0.017)。第7天出现膈肌萎缩的患者60天死亡的比值比为8.50([1.4 - 74],p = 0.029)。
在我们的研究中,膈肌厚度变化很常见,且与膈肌增厚分数无关。在持续VA - ECMO支持下早期拔管可使膈肌免于萎缩。器官功能衰竭和扫气流量导致的代谢紊乱与膈肌厚度变化有关。VA - ECMO存活者中保留的膈肌厚度强调了膈肌保护策略的重要性,包括精确的扫气流量滴定。